March 12, 2020 / 1:38 PM / in 17 days

BRIEF-Tetraphase Pharmaceuticals Reports Q4 Loss Per Share Of $2.75

March 12 (Reuters) - Tetraphase Pharmaceuticals Inc :

* TETRAPHASE PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND HIGHLIGHTS ACHIEVEMENTS AND KEY 2020 MILESTONES

* Q4 REVENUE $1.7 MILLION

* TETRAPHASE PHARMACEUTICALS - EXPECTS CASH,CASH EQUIVALENTS,INCLUDING EQUITY PROCEEDS & EXPECTED REVENUE, TO BE SUFFICIENT TO FUND OPERATIONS INTO Q1 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below